~," Recently, the benign nature of aneurysms of the cavernous carotid artery has been questioned. In a review of cases evaluated from 1980 to 1990 with this developmental aneurysm, the authors found 70 patients with 79 cavernous carotid artery aneurysms. As expected, the great majority (59 patients) had ophthalmoplegia as the initial problem. Retro-orbital pain (three cases) and a carotid-cavernous fistula (five cases) were infrequently the sole manifestation. Mirror-image asymptomatic aneurysms were found in nine patients and asymptomatic cavernous aneurysms were found in three additional patients. Thirty-four patients not surgically treated were followed for a mean of 2.8 years, and 36 surgical patients were followed for a mean of 4.1 years prior to treatment. Of the 79 aneurysms, one (1.3%) ruptured into the subarachnoid space during this period. Other than optic neuropathy or cranial neuropathy, no patient had a permanent neurological deficit; the 12 asymptomatic aneurysms remained asymptomatic. It is concluded that an aneurysm of the cavernous carotid artery is rarely associated with life-threatening complications, and treatment should be considered principally for patients with intolerable pain or problems related to vision.
S
PONTANEOUS or developmental aneurysms arising from the cavernous segment of the internal carotid artery (ICA) are rarely associated with lifethreatening complications. Early studies emphasized this knowledge when considering treatment. 2"~' 7"~3 Typically, patients harboring these lesions present with painful ophthalmoplegia or symptoms referable to another cerebral aneurysm and, less commonly, with signs of a spontaneous carotid-cavernous ~lStUla. 1" 2"6"8"9"12"14~2~ The ophthalmoplegia can have a gradually progressive or explosive onset. If the aneurysm is very large and extends anteriorly toward the optic foramen or anterosuperiorly through the dura, the patient can develop an optic neuropathy in addition to ophthalmoplegia. Cerebral ischemic episodes, from either emboli or thrombosis in the affected ICA, are also rare? Spontaneous subarachnoid hemorrhage (SAH) is rare enough to warrant individual case reports in the few who have experienced this complication ~'5'"~''~ (one of these cases has been reported more than once~5). Two pathologically studied patients with an SAH had an aneurysm that was definitively shown to have ruptured laterally, in the direction where there is normally no bone to support the vascular structures in the cavernous sinus.
Additional cases of SAH have been described with parasellar aneurysms, but clear documentation that the ruptured aneurysm neck arose only from the cavernous segment of the ICA was often lacking. ~7 The clinical course of a true cavernous carotid artery aneurysm differs from an aneurysm with an intradural origin and neck and a sac projecting extradurally into the cavernous sinus ~8 because the latter aneurysm frequently causes SAH. Another life-threatening complication, arterial epistaxis from rupture of an aneurysm into the sphenoid sinus, is even rarer than SAH. Most cases of epistaxis result from rupture of a pseudoaneurysm associated with trauma. 3'3 A recent report of 44 patients described a presentation of SAH in three and epistaxis in one, suggesting a 9% incidence of life-threatening complications. ~ However, this series is confounded by the inclusion of patients with aneurysms that extended to an intradural position, just proximal to the ophthalmic artery, as well as patients with traumatic pseudoaneurysms. This study prompted us to review our cases to determine if another modern-day experience with developmental cavernous carotid artery aneurysms was truly different from the classical teaching that these aneurysms were relatively benign. None of our patients presented with symptoms Benign course of cavernous carotid aneurvsms of SAH and we found only a 1.3% fl'cquency of SAH: therefore, we conclude that this aneurvsm is rarely lifethreatening.
Clinical Material and Methods
The records of all patients with cavernous carotid artery aneurysms referred to the New York University Neurovascular Service between 1980 and 1990 were reviewed. Seventy patients, 65 women and five men, with a mean age of 62 _+ 9.7 years (+ standard deviation) had a total of 79 cavernous aneurysms. All of these patients underwent complete neurological and neuro-ophthalmological clinical evaluation, performed by the first author (M.J.K.). In each case, computerized tomography (CT) and/or magnetic resonance (MR) imaging of the parasellar region were carried out. Cerebral angiography was performed in all patients and included studies of both ICA's and at least one vertebral artery. We included only patients with a cavernous carotid artery aneurysm arising from the ICA between the C-5 vertebral segment and prior to its upward sweep (C-3) and entrance into the intradural space. "~ This criterion excluded aneurysms with an origin either partially or entirely in the intradural or subarachnoid space. 's The angiogram often demonstrated an aneurysmal neck, but numerous cases lacked a definable neck because the wall of the cavernous ICA was part of the aneurysm wall.
Treatment Considerations
There were no prospective or absolute criteria for treatment. However, patients with progressive ophthalmoplegia, persistent diplopia in a primary position, severe trigeminal nerve pain, a compressive optic neuropathy, erosion of the wall of the sphenoid sinus, or a carotid-cavernous fistula were recommended for therapy. In general, patients who were unable to tolerate occlusion of the involved ICA and who were poor candidates for an external carotid artery system to middle cerebral artery bypass were not treated. Percutaneous intra-arterial embolizatioff j was the treatment implemented in most cases. In 1980, two patients underwent cervical ligation. In two cases, surgery directly on the cavernous aneurysm was performed at another institution. One patient with carotid-cavernous fistula was treated by manual compression. ~ Patients with untreated aneurysms were followed with repeat clinical examination and CT or MR imaging every 1 to 3 years.
Results

Clinical Presentation
The clinical presentation included ophthalmoplegia in 59 cases (Table 1) , three of which were painless; retro-orbital pain alone was identified in three cases and carotid-cavernous fistula in five cases. Three patients were asymptomatic and nine had asymptomatic mirror-image aneurysms. Nine of the 59 cases with :~ Seven patients suffered optic neuropathy.
ophthalmoplegia had a sudden painful onset; all of these improved spontaneously within 6 weeks. One additional patient with painful ophthalmoplegia had a concomilant contralateral hemiparesis lasting several weeks, which was associated with a disseminated inlravascular coagulopathy and spontaneous occlusion of the affected ICA. The asymptomatic cavernous aneurysms were found during evaluation for a ruptured intradural aneurysm in two cases, for a neoplasm in one case, and for symptomatic contralateral cavernous aneurysms (mirror image) in nine cases. Intradural aneurysms were found in seven cases (10%), and 22% of all patients had additional cerebral artery aneurysms. The aneurysms were asymptomatic prior to the development of the carotid-cavernous fistula in all cases. All of the aneurysms causing ophthalmoplegia were larger than 2.5 cm. The severity of the pain did not correlate with the size of the aneurysm and ophthalmoplegia; however, pain that included the distribution of the second or third division of the trigeminal nerve or optic neuropathy was seen only in the largest aneurysms. All aneurysms associated with a carotid-cavernous fistula were smaller than 2 cm. Only two of the 12 asymptomarie aneurysms were larger than 2.5 cm.
Group I: No Trealmenl
Thirty-four patients who were not recommended for surgical or embolization treatment (Group I) were followed for a mean of 2.8 _+ 1.3 years. This group included patients with sudden painful ophthalmoplegia, nonprogressive ophthalmoplegia, and no symptoms referable to this aneurysm.
The clinical follow-up findings for Group I are summarized in Table 2 . Only two patients developed new neurological problems related to the aneurysm. Painless progressive ophthalmoplegia and optic neuropathy occurred in one patient who had been asymptomatic for 8 years. Repeat MR imaging showed that the aneurysm had at least doubled from its original 3-cm size. This was the only aneurysm that increased in size in Group I. One patient had an unrelated brain-stem infarct 1 year after spontaneous resolution of a third nerve paresis. One patient had a cerebral infarct in the hemisphere contralateral to the aneurysm 2 years after diagnosis. One patient suffered an SAH 2.3 years after the onset of a partial third nerve paresis; the initial angiogram and MR image showed that the aneurysm had a nipple extending into the subarachnoid space (Fig. 1) . Because at the time of evaluation treatment would have required closure of the ICA after a bypass to the middle cerebral artery in the dominant hemisphere, it was elected to follow the patient without treatment. After direct surgical clipping of the aneurysm at another institution, the patient was neurologically intact except for the original ophthalmoplegia.
Group H. Late Treatment
Patients with carotid-cavernous fistulae were treated within weeks of the onset. These 36 patients (Group II) were symptomatic for a mean of 4.1 _+ 1.7 years prior to treatment. In this group, central nervous system dysfunction occurred in one patient who had an infarct in the ipsilateral cerebral hemisphere at presentation (discussed above). The final clinical examination in all Group II patients was normal or revealed only neuroophthalmological abnormalities (Table 3) .
Discussion
Our series confirms that many patients with cavernous carotid artery aneurysms have progression of a combination of third, fourth, and sixth nerve pareses, but the pain may be episodic or continuous. Approximately 25% of our untreated patients stabilized or improved spontaneously regardless of the size of the aneurysm. As postulated in other reports, spontaneous thrombosis within the giant aneurysm probably accounts for episodes of severe pain and worsening cranial neuropathy. These periods are often followed by a reduction or a complete resolution of the pain (usually within several days or weeks) and gradual improvement of the cranial nerve pareses (within weeks or months). In other patients, stability or spontaneous improvement of the cranial neuropathy gradually occurs without an acute event or severe pain. Once the symptoms have resolved, the patient remains asymptomatic from the aneurysm. Loss of vision is always preceded by the signs of cavernous sinus dysfunction, and all of our patients with an optic neuropathy had a complete oculomotor and pupillary paresis in the affected eye. Benign course of cavernous carotid aneurysms Except for one case, the asymptomatic aneurysms found at evaluation of symptomatic aneurysms in other locations were typically small and remained unchanged and asymptomatic for years. Approximately 6% of cavernous carotid artery aneurysms in this study ruptured into a venous compartment of the cavernous sinus, resulting in a carotid-cavernous fistula. Prior to rupture, these cases were asymptomatic and undiagnosed. Similar to other carotid-cavernous fistulae, the symptoms depended on the direction of the venous drainage, the location of thrombosis in the cavernous sinus, and the rate of blood flow through the shunt. Cerebral ischemia associated with a cavernous aneurysm occurred in one patient (1.4%) and was clearly related to an underlying coagulation disorder and spontaneous occlusion of the involved ICA. Delayed emboli from the thrombus in the aneurysm, another rare cause for these events, were not observed in this study.
No patient presented with an arterial epistaxis or symptoms of an SAH. Two patients with stable ophthalmoplegia underwent embolization therapy because of the increased risk of rupture into the sphenoid sinus with aneurysm bone erosion of the sphenoid sinus wall. Although epistaxis is not rare in patients with traumatic pseudoaneurysms, 3~3 we could find only one report docu meriting this complication in association with nontraumatic aneurysms. 2' One patient (1.4%) in our series developed an SAH more than 2 years after the onset of a nonprogressive ophthalmoplegia. Although many of the other patients had giant aneurysms extending into the middle fossa, this aneurysm was the only one with a distinct intradural component seen on MR imaging or angiography. There were no deaths in this series.
Conclusions
Our study clearly supports the classic concept that a cavernous carotid artery aneurysm is not a life-threatening disorder. Our results differ from other recent reports because we excluded traumatic lesions (which are not true aneurysms) and aneurysms that originate outside the cavernous carotid artery. Treatment is warranted in patients with debilitating ophthalmoplegia, pain, or loss of vision, and should also be considered in the rare circumstance of intradural extension of a nipple from the aneurysm dome. The therapeutic modality should be associated with a rate of severe morbidity at least as low as 1.4% and a lower incidence of mortality.
